A new method of segmental resection for primary lung cancer: intermediate results

Bando, Toru; Yamagihara, K; Ohtake, Yohsuke; Miyahara, Ryoji; Tanaka, Fumihiro; Hasegawa, Seiki; Inui, Kentaro; Wada, Hiromi

doi:10.1016/s1010-7940(02)00122-7

Cited by 62 publications

(28 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…there was no difference in median survival between sub-lobar resection and lobectomy, whereas for lesions of 2 to 3 cm in size survival was significantly better after lobectomy. Other studies reported no difference in survival and in local recurrence rate be- (14)(15). These observations areevident also in our study: analyzing patients with stage IA, there was no difference in 5 year survival and local recurrence rate between lobectomy and limited resection.…”

Section: Discussionsupporting

confidence: 90%

Sub-Lobar Lung Resection of Peripheral T1N0M0 NSCLC Does Not Affect Local Recurrence Rate

et al. 2009

View full text Add to dashboard Cite

Background and Aims:The use of sub-lobar resection versus lobectomy for stage In on small cell lung cancer is still controversial. This study was undertaken to compare the results of limited resection in terms of survival and local recurrence rate to lobectomy in patients with peripheral stage I non small cell lung cancer.Material and Methods: During the 8 year period from 1999 to 2007, 152 consecutive patients with stage I non-small cell lung cancer underwent lung resection at our thoracic surgery unit. In 116 cases we performed a standard lobectomy while in the remaining 36 cases we did subl obar resection through mini-thoracotomy or video-assisted thoracoscopy.The survival, local recurrence rate and the clinical outcome were analyzed and compared.Results: Fifty-one patients were staged as T1 N0 M0, 22 in the sub-lobar resection group (61,1%) and 29 (25%) in the lobectomy group. The remaining were staged as T2 N0 M0. Although the patient population undergone to sub-lobar resection was older,with poorer lung function and more co-morbidities, the Kaplan-Meier survival proportion at 5 year did not differ significantly between the two groups: 64% for lobectomy group vs 66,7% for sub-lobar resection group. Overall local recurrence did approach significance in favour of lobectomy group but analyzing only T1 patients, no differences in terms of survival and local recurrence rate were observed.Conclusions: The results of this study indicate that in patients with peripheral T1N0M0 non small cell lung cancer the outcome of limited resection is comparable with that of pulmonary lobectomy.

show abstract

Section: Discussionsupporting

confidence: 90%

Sub-Lobar Lung Resection of Peripheral T1N0M0 NSCLC Does Not Affect Local Recurrence Rate

et al. 2009

View full text Add to dashboard Cite

show abstract

“…The other group reported no difference between segmentectomy and lobectomy in patients with tumors < 2 cm in diameter. 14) These results support segmentectomy as a surgical option to cure small NSCLC. In our study, the 5-year survival rates of VATS segmentectomy were similar to a previous report.…”

Section: Discussionmentioning

confidence: 62%

Ki-67 Labeling Index Is Associated with Recurrence after Segmentectomy under Video-assisted Thoracoscopic Surgery in Stage I Non-small Cell Lung Cancer

Yamashita

Moroga

Tokuishi

et al. 2011

ATCS

View full text Add to dashboard Cite

In the relapsed patients, 3 (6.8%) were local recurrences and 2 (4.5%) were distant metastases. There was no significant difference between clinicopathological factors and recurrence; however, patients with Ki-67 LI less than 5% showed better disease-free survival than patients with Ki-67 LI over 5% (p = 0.04). In multivariate Cox regression analysis, although there was no significantly different in disease-free survival by age, histology, tumor size, only Ki-67 LI showed a significant prognostic factor of recurrence (HR = 12.5, 95% CI = [1.1-1407], p = 0.04). Conclusions: Ki-67 LI after VATS segmentectomy was a prognostic factor of disease-free survival in NSCLC and the treatment of choice for patients with positive LI may be considered, in addition to adjuvant chemotherapy, or lobectomy.

show abstract

“…The favorable 5-y survival of 87.1% in the segmentectomy group was shown against 87.7% in the lobectomy group. The other group reported a lack of difference between segmentectomy and lobectomy in patients with tumors less than 2 cm in diameter [12]. Furthermore, Fernando et al showed improved survival in the lobectomy group compared to segmentectomy for patients with tumors of 2 to 3 cm in diameter even if patients with tumors less than 2 cm showed no difference between segmentectomy and lobectomy [13].…”

Section: Discussionmentioning

confidence: 99%

Clinical Impact of Segmentectomy Compared with Lobectomy Under Complete Video-Assisted Thoracic Surgery in the Treatment of Stage I Non-Small Cell Lung Cancer

Yamashita

Chujo

Kawano

et al. 2011

Journal of Surgical Research

View full text Add to dashboard Cite

A new method of segmental resection for primary lung cancer: intermediate results

Abstract: Our intermediate results demonstrated that the new pulmonary artery-guided segmentectomy could be an alternative method for selected patients with small lung cancer, particularly with tumors 20 mm or smaller in diameter.

Cited by 62 publications

References 14 publications

Sub-Lobar Lung Resection of Peripheral T1N0M0 NSCLC Does Not Affect Local Recurrence Rate

Sub-Lobar Lung Resection of Peripheral T1N0M0 NSCLC Does Not Affect Local Recurrence Rate

Ki-67 Labeling Index Is Associated with Recurrence after Segmentectomy under Video-assisted Thoracoscopic Surgery in Stage I Non-small Cell Lung Cancer

Clinical Impact of Segmentectomy Compared with Lobectomy Under Complete Video-Assisted Thoracic Surgery in the Treatment of Stage I Non-Small Cell Lung Cancer

Contact Info

Product

Resources

About